DDRT

DanDrit Biotech USA, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 11/16/2017
Contact Info
  • Stumpedyssevej 17
  • Horsholm 2970
  • Denmark

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-K
CIK 0001527728
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2011
Employees 3 a/o Dec 23, 2016
Company Officers/Contacts
Eric Leire CEO
Robert E. Wolfe CFO
Company Directors
Henrik Grønfeldt-Sørensen
Eric Leire
Rene Sindlev
Robert E. Wolfe
Service Providers
Accounting/Auditing Firm
Gregory & Associates, LLC
19 120th Street
Ocean City, MD, 21842
United States

Legal Counsel
K&L Gates LLP
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States

Investor Relations Firm
Not Available
DDRT Security Details
Share Structure
Market Value1 $46,673,629 a/o Nov 16, 2017
Authorized Shares 100,000,000 a/o Sep 28, 2016
Outstanding Shares 13,727,538 a/o Sep 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 7,402,528 a/o Sep 28, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Action Stock Transfer Corporation
Shareholders
Shareholders of Record 75 a/o Sep 28, 2016
Short Selling Data
Short Interest 1,370 (-3.04%)
Oct 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security